Xiangdong Zhou

4PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Computer vision
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 14, 2025
SuFu somatic mutations are recognized as novel markers for genomic instability and tumor growth in lung adenocarcinoma.

Ji-Hong Liu, Tao Zhang, Yan Wang

|Mar 21, 2022
Tocilizumab, an Exploratory Treatment for Severe COVID-19 Patients.

Yong Wang, Yongfeng Chen, Xiangdong Zhou

|Nov 18, 2020
Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions?

Yong Wang, Qing Mao, Xiangdong Zhou

Pageof 1